LBTSF News and Press, Almirall Sa Ord From 02/22/21

Almirall, S.A. (LBTSF): FY normalized Net Income of €95.1MRevenue of €814.5M (-10.3% Y/Y)Press Release For further details see: Almirall, S.A. reports FY results

Almirall's 2020 Full-Year Results Almirall delivers on latest 2020 guidance and sets growth targets for 2021 PR Newswire BARCELONA, Spain , Feb. 22, 2021 /PRNewswire/ -- The company delivered on its latest guidance despite a challenging year impacted ...

Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis -- In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque psoriasis in...

Almirall announces Gianfranco Nazzi as new CEO Gianfranco Nazzi brings broad international experience from a distinguished career in Pharma Mr. Nazzi will join Almirall as Chief Executive Officer on May 1, 2021 PR Newswire BARCELONA, Spain , Feb. 3, 2021 ...

Almirall and Happify Health enter into strategic partnership to develop evidence-supported digital therapeutics solutions for psoriasis patients -- The goal of this strategic partnership is to develop digital solutions to improve the lives of patients with psoriasis based on cog...

Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies - The goal of this strategic partnership is to develop ground-breaking drugs for the treatment of debilitating genetic dermatological conditions - Tyris' expertise in n...

Athenex (ATNX) jumps 10% premarket on after FDA approved Klisyri (tirbanibulin) for the topical treatment of actinic keratosis ((AK)) on the face or scalp.Klisyri is the first FDA approved branded proprietary product for Athenex and will be launched in partnership with Almirall (LBT...

Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau PR Newswire BARCELONA, Spain, Nov. 24, 2020 BARCELONA, Spain , Nov. 24, 2020 /PRNewswire/ -- AlmirallSha...

Pablo Alvarez appointed to President and GM of Almirall US - Pablo will report directly to the CEO and serve on the Management Board effective immediately - He brings to this important role broad international pharmaceutical industry experience, including nearly 10 years in ...

The following slide deck was published by Almirall, S.A. in conjunction with their 2020 Q3 earnings call. For further details see: Almirall, S.A. 2020 Q3 - Results - Earnings Call Presentation